Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Identify errors and issues in the following transaction: 1 . WHS received regulatory approval on a new supplement which reduces inflammation and arthritis in cats.

Identify errors and issues in the following transaction:
1. WHS received regulatory approval on a new supplement which reduces inflammation and arthritis in
cats. The company has developed this product over the last five years. Buoyed by the success of the
commercialisation and approval of the new product WHS capitalised $1,000,000 in research costs
which had been expensed in prior periods as the directors have assessed this amount to commercially
reflect of the value of the brand.
2. Byron Glow Pty Ltd pays administration and research facility fees of $15,000 and $10,000 respectively
each month to WHS. The research fees are payable on the last day of each month and the
administration fees are payable on the 10th day following the end of each month.
3. WHS lent Byron Glow $2,500,000 to assist with the commercialisation of their revolutionary newly
patented medical device which assists hearing impaired dogs. The loan is interest only, with interest
charged at 4.25 per cent per annum and paid on the last day of each month. The loan is expected to
be repaid in full on 25 January 2025.
4. A competitor of Byron Glow Pty Ltd released a new device to market which is technologically superior
to a similar device sold by Byron Glow Pty Ltd. Byron Glow Pty Ltd has ceased production of this device,
however, believes demand will continue for their remaining inventory.
5. WHS sold laboratory equipment to Byron Glow Pty Ltd on 20 March 2024. The laboratory equipment
was originally acquired for $80,000 on 1 July 2020 and was sold for $35,000. The laboratory equipment
was being depreciated by WHS on a straight-line basis over five years. Byron Glow Pty Ltd has assessed
that the laboratory equipment acquired has a remaining useful life of two years.
6. Goodwill on acquisition was impaired by $30,000 in the year ended 30 June 2023. The directors have
requested the impairment be reversed in the current year.
7. WHS recorded a $450,000 revaluation increment in relation to the land owned on the Gold Coast.
8. Byron Glow Pty Ltd leased research facilities in Melbourne on 1 July 2023. The new facilities are in
response to the increasing demand for their products in the Victorian and South Australia regions. The
CFO advised the lease is to be accounted for as an annual expense as the company does not intend to
own the premises at the end of the lease. Annual lease payments of $250,000 are paid in full on the
last day of the year. You note from reading the related documents, the implicit interest rate is 5.85%
and the lease term is non-cancellable for a period of five years.
9. Byron Glows returns policy is that veterinarian customers can return therapeutic devices acquired
within fourteen days of the sale for a full refund provided the item is unused. Approximately 2.5% of
sales are returned for a refund. The groups accounting policy for revenue is to book the full price of
all sales at the time sales occur and recognise any refunds at the time items are returned and a refund
is issued to the customer. The average gross profit margin for therapeutic devices is 65%.
10. WHS does not have a formalised returns policy due to the nature of the compound medication. Once
opened it cannot be returned for refund.
11. On 15 June 2024, WHS received legal notification that a class action has commenced against the
company. The class action alleges the company was negligent and is seeking $5,000,000 in damages
plus costs. The companys lawyers have advised the claim against the company appears to be spurious
in nature. The Company denies any wrongdoing, however, to be prudent a provision of $250,000 has
been included in the year-end financial statements to cover potential legal costs. As the action is in
its early stages, no court dates have been set.
12. On 30 June 2024 WHS issued $250,000 preference shares which are redeemable on 15 June 2025 and
pay a dividend of 10% p.a, paid on a quarterly basis. The dividends are cumulative.
13. The company is considering changing its accounting policy in relation to land and buildings to measure
land and buildings at cost, so that all property, plant and equipment is measured at cost from 1 July
2024.
14. The CFO advised they had heard that extra disclosures are required in relation to consolidated
financial statements and has asked you to provide a brief summary as to what the new requirements
are and whether they will affect the preparation of the consolidated financial statements and related
annual report.
15. All amounts are expressed exclusive of GST. GST is not required to be incorporated into the
transactions or adjustments for the purposes of this exercise.

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Financial Accounting

Authors: Jane L. Reimers

1st Edition

0131492012, 978-0131492011

More Books

Students also viewed these Accounting questions

Question

What are the pros and cons when 2 major restaurant chains merge?

Answered: 1 week ago